Franklin Biotechnology Discovery Fund Class C
FBTDX
NASDAQ
| Weiss Ratings | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton Investments | |||
| Manager/Tenure (Years) | Evan S. McCulloch (28), Akiva Felt (6) | |||
| Website | http://www.franklintempleton.com | |||
| Fund Information | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Franklin Biotechnology Discovery Fund Class C | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Mar 04, 2014 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.35% | |||
| Dividend | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.35% | |||
| Asset Allocation | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.38% | |||
| Stock | 97.30% | |||
| U.S. Stock | 90.06% | |||
| Non-U.S. Stock | 7.24% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 1.32% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.80% | |||
| 30-Day Total Return | -9.98% | |||
| 60-Day Total Return | -0.08% | |||
| 90-Day Total Return | 8.55% | |||
| Year to Date Total Return | 15.53% | |||
| 1-Year Total Return | 51.40% | |||
| 2-Year Total Return | 50.83% | |||
| 3-Year Total Return | 106.62% | |||
| 5-Year Total Return | 59.60% | |||
| Price | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $170.40 | |||
| 1-Month Low NAV | $170.40 | |||
| 1-Month High NAV | $189.31 | |||
| 52-Week Low NAV | $125.34 | |||
| 52-Week Low NAV (Date) | Sep 19, 2025 | |||
| 52-Week High NAV | $189.31 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.66 | |||
| Standard Deviation | 20.73 | |||
| Balance Sheet | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.22B | |||
| Operating Ratios | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.76% | |||
| Turnover Ratio | 37.62% | |||
| Performance | FBTDX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 62.15% | |||
| Last Bear Market Total Return | -11.97% | |||